168 related articles for article (PubMed ID: 7026144)
21. [Effects of delayed-action metoprolol evaluated in hypertensive patients responsive to therapy subdivided in 2 different age groups].
Carpentiere G; Marino S; Castello F; Castello A; Cellura M
G Ital Cardiol; 1984 Jul; 14(7):530-3. PubMed ID: 6489667
[TBL] [Abstract][Full Text] [Related]
22. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
[TBL] [Abstract][Full Text] [Related]
23. [Protection of the hypertensive patient: comparative study of atenolol and metoprolol].
Mazzari M; Coppola E; Montenero AS; Schiavoni G; Domenichelli B; Mongiardo R; Pennestrì F
Cardiologia; 1982; 27(8):753-63. PubMed ID: 6765444
[No Abstract] [Full Text] [Related]
24. [Effect and concentration in plasma of metoprolol after administration in the morning and in the evening in essential hypertension].
Edvardsson N; Fritz H; Hällén J; Larsson R; Norlander S; Rasmussen PA
Lakartidningen; 1978 Mar; 75(11):1069-72. PubMed ID: 345028
[No Abstract] [Full Text] [Related]
25. [Comparative double-blind, crossover and randomized study of the antihypertensive activity of nifedipine in primary arterial hypertension].
de Mendonça JV; de Castro Filho J
Arq Bras Cardiol; 1984 Sep; 43(3):219-22. PubMed ID: 6398995
[No Abstract] [Full Text] [Related]
26. A controlled evaluation of metoprolol.
Woollard KV; Harris AM
Practitioner; 1978 Dec; 221(1326):941-3. PubMed ID: 372937
[No Abstract] [Full Text] [Related]
27. [Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy].
Bozza AE; Guimarães FJ; de Carvalho FJ; Santos LC; Pellon FM; de Castro RF; Balbuena RR
Arq Bras Cardiol; 1984 Sep; 43(3):213-7. PubMed ID: 6398994
[No Abstract] [Full Text] [Related]
28. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA
Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440
[TBL] [Abstract][Full Text] [Related]
29. Treatment of essential hypertension. A comparison between nadolol, once daily, and propranolol, four times daily.
Frithz G
Practitioner; 1982 Mar; 226(1365):562-4. PubMed ID: 7045847
[No Abstract] [Full Text] [Related]
30. Antihypertensive effects of metoprolol and reserpine-hydrochlorothiazide.
Lochaya S; Jansiriskul V; Srivorpongpan R; Jiamsucson K; Suvachittanont O
J Med Assoc Thai; 1982 Apr; 65(4):203-12. PubMed ID: 7050277
[No Abstract] [Full Text] [Related]
31. Comparative study of hydrochlorothiazide and a fixed combination of metoprolol and hydrochlorothiazide essential hypertension.
Dafgärd T; Forsén B; Lindahl T
Ann Clin Res; 1981; 13 Suppl 30():37-44. PubMed ID: 7027892
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study].
Grotemeyer KH; Schlake HP; Husstedt IW
Nervenarzt; 1988 Sep; 59(9):549-52. PubMed ID: 3054595
[No Abstract] [Full Text] [Related]
33. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
Frishman WH; Hainer JW; Sugg J;
Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
[TBL] [Abstract][Full Text] [Related]
34. Atenolol in hypertension: a double-blind comparison of the response to three different doses.
Zacharias FJ; Hayes PJ; Cruickshank JM
Postgrad Med J; 1977; 53 Suppl 3():114-5. PubMed ID: 337265
[No Abstract] [Full Text] [Related]
35. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
36. A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group.
Baird MG; Bentley-Taylor MM; Carruthers SG; Dawson KG; Laplante LE; Larochelle P; MacCannell KL; Marquez-Julio A; Silverberg LR; Talbot P
Clin Invest Med; 1984; 7(2):95-102. PubMed ID: 6380858
[TBL] [Abstract][Full Text] [Related]
37. Double-blind comparison of long acting propranolol and sustained release metoprolol in the treatment of angina pectoris.
Irving JB; Edwards RE
Br J Clin Pract; 1987 Aug; 41(8):872-5. PubMed ID: 3329528
[No Abstract] [Full Text] [Related]
38. [New selective beta 1-receptor antagonist. A comparison of metoprolol (Seloken) and placebo in mild to moderate hypertension].
Andreassen PH; Drivenes A
Tidsskr Nor Laegeforen; 1977 Aug; 97(22):1081-3, 78. PubMed ID: 333653
[No Abstract] [Full Text] [Related]
39. [Metoprolol in the treatment of hypertension].
Mayer O; Rottenborn J; Polívková H
Vnitr Lek; 1988 Feb; 34(2):130-7. PubMed ID: 3284180
[No Abstract] [Full Text] [Related]
40. [Hypertension therapy with metoprolol--comparison between single and double doses].
Callans A; Dafgård T; Jäderberg E; Lindahl T; Sandefeldt A
Lakartidningen; 1979 Apr; 76(17):1628-30. PubMed ID: 449458
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
